SINOVAC BIOTECH LTD. - Common Shares (SVA)

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Shares
Shares outstanding: 71.9M
Number of holders: 15
Total 13F shares, excl. options: 9.48M
Shares change: +5.9M
Total reported value, excl. options: $60.1M
Value change: +$38.2M
Number of buys: 2
Price: $6.47

Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2020

15 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q1 2020.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.48M shares of 71.9M outstanding shares and own 13.19% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (5.9M shares), ORBIMED ADVISORS LLC (2.84M shares), Neumann Advisory Hong Kong Ltd (316K shares), STATE STREET CORP (161K shares), Yorktown Management & Research Co Inc (74.9K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (68.7K shares), Skandinaviska Enskilda Banken AB (publ) (40K shares), GEODE CAPITAL MANAGEMENT, LLC (27.7K shares), Eqis Capital Management, Inc. (20.7K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (16.4K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.